Clinical Trial Update: Single-Cell Sequence Technology Used to Reveal Heterogeneity of Secondary Hyperparathyroidism

View source ↗

Summary

A clinical trial update describes using single-cell sequencing to reveal cellular heterogeneity in secondary hyperparathyroidism. The study is currently active …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperparathyroidism

Snippet

Sponsor: China-Japan Friendship Hospital | Conditions: Secondary Hyperparathyroidism | Status: ACTIVE_NOT_RECRUITING